University of California San Francisco

Michael Ou
Michael Ou, MD

Resident (PGY-3) 
General Surgery

    Education

    Institution Degree Dept or School End Date
    Johns Hopkins School of Medicine M.D. 05/2022
    Johns Hopkins University B.S. Neuroscience 05/2016

    Publications

    MOST RECENT PUBLICATIONS FROM A TOTAL OF 19
    1. PASC in Solid Organ Transplant Recipients With Self-reported SARS-CoV-2 Infection.
      Alasfar S, Chiang TP, Snyder AJ, Ou MT, Boyarsky BJ, Abedon AT, Alejo JL, Cook S, Cochran W, Brigham E, Parker AM, Garonzik-Wang J, Massie AB, Brennan DC, Vannorsdall T, Segev DL, Avery RK| | PubMed
    2. Low-volume hospitals are not associated with inferior outcomes after thoracic endovascular aortic repair.
      Alhajri N, Yin K, Locham S, Ou M, Malas MB| | PubMed
    3. SARS-CoV-2 Messenger RNA Vaccine Immunogenicity in Solid Organ Transplant Recipients With Prior COVID-19.
      Boyarsky BJ, Barbur I, Chiang TP, Ou MT, Greenberg RS, Teles AT, Krach MR, Lรณpez JI, Garonzik-Wang JM, Avery RK, Massie AB, Segev DL, Werbel WA| | PubMed
    4. Antibody Kinetics and Durability in SARS-CoV-2 mRNA Vaccinated Solid Organ Transplant Recipients.
      Boyarsky BJ, Chiang TP, Teles AT, Greenberg RS, Krach MR, Ou MT, Massie AB, Tobian AAR, Garonzik-Wang JM, Segev DL, Werbel AWA| | PubMed
    5. Safety and Reactogenicity of 2 Doses of SARS-CoV-2 Vaccination in Solid Organ Transplant Recipients.
      Ou MT, Boyarsky BJ, Motter JD, Greenberg RS, Teles AT, Ruddy JA, Krach MR, Jain VS, Werbel WA, Avery RK, Massie AB, Segev DL, Garonzik-Wang JM| | PubMed
    6. Antibody Response to Severe Acute Respiratory Syndrome-Coronavirus-2 Messenger RNA Vaccines in Liver Transplant Recipients.
      Strauss AT, Hallett AM, Boyarsky BJ, Ou MT, Werbel WA, Avery RK, Tobian AAR, Massie AB, Hamilton JPA, Garonzik-Wang JM, Segev DL| | PubMed
    7. Immunogenicity and Reactogenicity After SARS-CoV-2 mRNA Vaccination in Kidney Transplant Recipients Taking Belatacept.
      Ou MT, Boyarsky BJ, Chiang TPY, Bae S, Werbel WA, Avery RK, Tobian AAR, Massie AB, Segev DL, Garonzik-Wang JM| | PubMed
    8. SARS-CoV-2 messenger RNA vaccine antibody response and reactogenicity in heart and lung transplant recipients.
      Hallett AM, Greenberg RS, Boyarsky BJ, Shah PD, Ou MT, Teles AT, Krach MR, Lรณpez JI, Werbel WA, Avery RK, Bae S, Tobian AA, Massie AB, Higgins RSD, Garonzik-Wang JM, Segev DL, Bush EL| | PubMed
    9. Antibody Response to the Janssen COVID-19 Vaccine in Solid Organ Transplant Recipients.
      Boyarsky BJ, Chiang TP, Ou MT, Werbel WA, Massie AB, Segev DL, Garonzik-Wang JM| | PubMed
    10. Safety and Immunogenicity of a Third Dose of SARS-CoV-2 Vaccine in Solid Organ Transplant Recipients: A Case Series.
      Werbel WA, Boyarsky BJ, Ou MT, Massie AB, Tobian AAR, Garonzik-Wang JM, Segev DL| | PubMed